巨细胞动脉炎和风湿性多肌痛的目标治疗推荐
该指南由10个国家29名参与者组成的特别工作组制定,基于系统文献综述与专家意见,采用投票达成共识,提出5项总体原则和6项具体推荐。管理应基于医患共同决策,认识到巨细胞动脉炎需紧急治疗以避免缺血性并发症,两种疾病均应最大化健康相关生活质量。治疗目标为达到并维持缓解,以及预防组织缺血和血管损伤。
要点
- 巨细胞动脉炎和风湿性多肌痛的管理应基于医患共同决策。
- 巨细胞动脉炎需紧急治疗以避免缺血性并发症。
- 治疗目标为达到并维持缓解,预防组织缺血和血管损伤。
核心结论
- 这是首部针对巨细胞动脉炎和风湿性多肌痛的目标治疗推荐,已定义治疗目标及评估、达到和维持这些目标的策略。
研究设计与样本
- 系统文献综述检索巨细胞动脉炎/风湿性多肌痛的治疗目标和结局数据及目标治疗管理有效性的证据。
- 特别工作组由来自10个国家的29名参与者组成,包括医生、一名医疗专业人员和一名患者,基于证据和专家意见制定推荐,通过投票达成共识,最终同意水平以匿名方式提供。
主要发现
- 制定了5项总体原则和6项具体推荐。
- 管理应基于医患共同决策,认识到巨细胞动脉炎需紧急治疗以避免缺血性并发症,两种疾病均应最大化健康相关生活质量。
- 治疗目标为达到并维持缓解,以及预防组织缺血和血管损伤。
- 评估疾病活动和选择治疗时需考虑合并症。
关键数值与推荐
- 5项总体原则和6项具体推荐。
- 治疗目标为达到并维持缓解,以及预防组织缺血和血管损伤。
临床怎么用
- 管理巨细胞动脉炎和风湿性多肌痛应基于医患共同决策。
- 应认识到巨细胞动脉炎需紧急治疗以避免缺血性并发症。
- 两种疾病均应最大化健康相关生活质量。
- 治疗目标为达到并维持缓解,以及预防组织缺血和血管损伤。
- 评估疾病活动和选择治疗时需考虑合并症。
局限性
- 研究议程强调了证据缺口和未来研究的需要。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To develop treat-to-target (T2T) recommendations in giant cell arteritis (GCA) and polymyalgia rheumatica (PMR). METHODS: A systematic literature review was conducted to retrieve data on treatment targets and outcomes in GCA/PMR as well as to identify the evidence for the effectiveness of a T2T-based management approach in these diseases. Based on evidence and expert opinion, the task force (29 participants from 10 countries consisting of physicians, a healthcare professional and a patient) developed recommendations, with consensus obtained through voting. The final level of agreement was provided anonymously. RESULTS: Five overarching principles and six-specific recommendations were formulated. Management of GCA and PMR should be based on shared decisions between patient and physician recognising the need for urgent treatment of GCA to avoid ischaemic complications, and it should aim at maximising health-related quality of life in both diseases. The treatment targets are achievement and maintenance of remission, as well as prevention of tissue ischaemia and vascular damage. Comorbidities need to be considered when assessing disease activity and selecting treatment. CONCLUSION: These are the first T2T recommendations for GCA and PMR. Treatment targets, as well as strategies to assess, achieve and maintain these targets have been defined. The research agenda highlights the gaps in evidence and the need for future research.
引用
- Dejaco C, Kerschbaumer A, Aletaha D, et al. Treat-to-target recommendations in giant cell arteritis and polymyalgia rheumatica. Ann Rheum Dis. 2024. PMID: 36828585. doi:10.1136/ard-2022-223429
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。